James Mojirade 4
4 · AVANOS MEDICAL, INC. · Filed Mar 6, 2025
Insider Transaction Report
Form 4
James Mojirade
SVP, General Counsel
Transactions
- Exercise/Conversion
Common Stock
2025-03-04+8,039→ 78,352 total - Tax Payment
Common Stock
2025-03-04$15.13/sh−2,636$39,883→ 75,716 total - Tax Payment
Common Stock
2025-03-04$15.13/sh−2,068$31,289→ 73,648 total
Footnotes (3)
- [F1]Represents performance-based restricted share units (PRSUs) which: (i) were awarded to the Reporting Person on March 4, 2022 and (ii) vested on March 4, 2025. Each PRSU is the economic eqiuvalent of one share of Common Stock.
- [F2]Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 8,039 PRSUs which vested on March 4, 2025.
- [F3]Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 6,880 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 4, 2022 and (ii) vested on March 4, 2025. Each TRSU is the economic equivalent of one share of Common Stock.